Chemo Pharma Laboratories Ltd. announced unaudited earnings results for the third quarter and nine months ended December 31, 2013. For the quarter, the company reported total income from operations of INR 22.7 million compared to INR 0.2 million a year ago. Profit from operations before other income, finance cost and exceptional items was INR 10 million compared to loss from operations before other income, finance cost and exceptional items of INR 10.6 million a year ago. Profit from ordinary activities before tax was INR 10 million compared to loss from ordinary activities before tax of INR 10.6 million a year ago. Net profit for the period was INR 10 million compared to net loss for the period of INR 10.6 million a year ago. Basic and diluted EPS before and after extraordinary items was INR 0.07 compared to basic and diluted LPS before and after extraordinary items of INR 0.07 a year ago.

For the nine months, the company reported total income from operations of INR 201.4 million compared to INR 73.4 million a year ago. Profit from operations before other income, finance cost and exceptional items was INR 132.9 million compared to loss from operations before other income, finance cost and exceptional items of INR 1.5 million a year ago. Profit from ordinary activities before tax was INR 132.9 million compared to loss from ordinary activities before tax of INR 1.5 million a year ago. Net profit for the period was INR 132.9 million compared to net loss for the period of INR 1.5 million a year ago. Basic and diluted EPS before and after extraordinary items was INR 0.89 compared to basic and diluted LPS before and after extraordinary items of INR 0.22 a year ago.